Filing Details

Accession Number:
0001396814-25-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-06-05 17:40:22
Reporting Period:
2025-06-03
Filing Date:
2025-06-05
Accepted Time:
2025-06-05 17:40:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1545439 Lauren Riker C/O Pacira Biosciences, Inc.
2000 Sierra Point Parkway, Suite 900
Brisbane CA 94005
Senior Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2025-06-03 3,374 $26.40 65,142 No 4 F Direct
Common Stock Disposition 2025-06-04 5,578 $26.21 59,564 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.15 to $26.38, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2.